Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Evaluation of Effectiveness and Safety of Belotero Balance® (+) Lidocaine for Volume Augmentation of the Infraorbital Hollow

ClinicalTrials.gov ID: NCT04594239

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04594239. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 3:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

* Confirm the effectiveness of Belotero Balance® (+) Lidocaine (BBL) injection for the correction of volume loss in the infraorbital hollow (IOH) area by demonstrating superiority to untreated control. * Confirm the safety of BBL injection for the correction of volume loss in the IOH area.

Study identification

NCT ID
NCT04594239
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Merz North America, Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
22 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2020 (Actual)
Primary completion
Apr 8, 2021 (Actual)
Completion
Jun 21, 2022 (Actual)
Last update posted
Jan 30, 2024

2020 – 2022

United States locations

U.S. sites
8
U.S. states
5
U.S. cities
8
Facility City State ZIP Site status
Art of Skin MD, Merz Investigational Site #0010444 Solana Beach California 92075 —
Moradi MD Face Beautiful Inc., Merz Investigational Site #0010358 Vista California 92083 —
MetroDerm / Atlanta Center for Clinical Research, Merz Investigational Site #0010446 Atlanta Georgia 30342 —
Project Glammers, Merz Investigational Site #0010443 Brooklyn New York 11229 —
The Center for Dermatology, Cosmetic & Laser Surgery, Merz Investigational Site #0010442 Mount Kisco New York 10549 —
Mariwalla Dermatology, Merz Investigational Site #0010445 West Islip New York 11795 —
HKB Surgeons, Merz Investigational Site #0010447 Huntersville North Carolina 28078 —
Nashville Centre for Laser & Facial Surgery, Merz Investigational Site #0010353 Nashville Tennessee 37203 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04594239, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2024 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.